Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2023-02-15 00:00:00 ET · period of report 2023-02-13 · accession 0001787306-23-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-15 | 2023-02-13+ | ARQT | Watanabe Todd Franklin | See Remarks, Dir | S - Sale | $17.01 | -1,000 | 377.0K | -0.3% | -$17.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | S | D | 100 | $17.03 | 376,907 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-13 | S | D | 441 | $17.00 | 377,466 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-13 | S | D | 42 | $17.01 | 377,424 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-14 | S | D | 417 | $17.02 | 377,007 | D | — | — |